Medifast Inc income statement

In fiscal 2025, Medifast Inc reported revenue of $386m, down 36.0% on the year before, operating income of −$14.2m (a -3.7% margin) and net income of −$18.7m, or −$1.70 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Medifast Inc: income statement, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMSept 2026
Revenue	170	258	298	319	324	285	273	275	302	501	714	935	1,526	1,599	1,072	602	386	300
Cost of revenue	45	65	74	83	83	76	71	69	74	121	177	237	398	458	296	158	111	92
Gross profit	124	192	224	236	241	209	201	206	228	380	537	698	1,128	1,140	776	445	275	207
Research and development	—	—	—	—	—	1	2	2	2	2	3	3	4	5	5	5	4	—
Selling, general and administrative	106	161	197	209	202	179	173	179	188	311	446	564	911	956	649	442	289	242
Operating income	18	32	27	27	38	30	29	27	40	69	91	134	216	185	126	3	−14	−35
Interest expense	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	—	—
Income before tax	18	32	28	28	39	32	30	27	40	71	92	134	216	184	129	4	−6	−29
Income tax	7	12	9	10	12	11	10	9	13	15	14	31	52	40	29	2	13	12
Net income	11	20	19	16	24	13	20	18	28	56	78	103	164	144	99	2	−19	−41
Diluted EPS	$0.77	$1.35	$1.31	$1.16	$1.73	$1.03	$1.66	$1.49	$2.29	$4.62	$6.43	$8.68	$13.89	$12.73	$9.10	$0.19	−$1.70	−$3.69
Diluted shares (average)	15m	15m	14m	14m	14m	13m	12m	12m	12m	12m	12m	12m	12m	11m	11m	11m	11m	11m
EBITDA	24	37	36	36	46	38	36	32	44	73	96	138	223	196	140	16	0	−22

US$ millions unless shown otherwise. Fiscal quarters.

Medifast Inc: income statement, quarterly
Quarter	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026	2026 Q3Sept 2026
Revenue	119	116	106	89	75	76	76	72
Cost of revenue	31	31	29	27	23	24	23	22
Gross profit	88	84	77	62	52	52	53	50
Selling, general and administrative	88	86	78	66	60	55	58	69
Operating income	1	−1	−1	−4	−8	−3	−4	−19
Income before tax	1	1	3	−3	−6	−2	−3	−18
Income tax	0	1	0	−0	12	0	0	−0
Net income	1	−1	2	−2	−18	−2	−3	−18
Diluted EPS	$0.07	−$0.07	$0.22	−$0.21	−$1.65	−$0.19	−$0.28	−$1.57
EBITDA	4	2	3	−1	−4	0	−1	−17

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LWAY vs MED BRID vs MED MAMA vs MED

More: Packaged Foods & Meats stocks compared, Consumer Staples sector, rankings of US companies

Figures from Medifast Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medifast Inc.